Jan 10, 2022 | Featured, Research News, Technology Updates
What’s Going on with the Dexcom G7? was reported by Ross Wollen for DiabetesDaily.com, 3 January 2022. What’s going on with the Dexcom G7? Patients (and investors) want to know! Dexcom has been hyping the next generation of its groundbreaking continuous glucose...
Jan 3, 2022 | Featured, Research News, Technology Updates
Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial and Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial was released by Beta Bionics on GlobeNewswire.com, 22 December 2021. Beta Bionics,...
Dec 20, 2021 | Featured, Research News, Technology Updates
DIABETES BUSINESS NEWS: Diabetes tech market still has a clear favorite was published by Jason Aycock for SeekingAlpha.com, 15 December 2021. On the Continuous Glucose Monitoring, the market stayed strong this year, likely growing in the low-...
Dec 13, 2021 | Featured, Research News, Technology Updates
Tandem Diabetes Care targets 1M customers by 2027 we reported by Ricky Zipp for MedTechDive.come, 7 December 2021. Tandem Diabetes Care projects that its worldwide customer base will triple to 1 million by 2027 as the insulin pump maker launches multiple...
Dec 6, 2021 | Featured, Research News, Technology Updates
Insulet drops 10% as CEO indicates launch of Omnipod insulin product likely delayed was reported by Jonathan M. Block for SeekingAlpha.com, 3 December 2021. Insulet CEO Shacey Petrovic said that the FDA will likely not complete its review of the...
Nov 27, 2021 | Featured, Research News
I’ve always said that IF there is a cure for Type 1 diabetes, it will be on the front page of The New York Times. Well, here it is, from today’s (Saturday, 27 November 2021) front section of the digital version of the NYTimes, in bold print … A Cure...